Indian firm seeks denial of Sovaldi patent

|By:, SA News Editor

Domestic generic drug maker Natco Pharma Ltd asks the Indian patent office to deny Gilead's (GILD) Sovaldi patent in the country saying it is not "inventive" enough.

If the request is successful generic drug makers may launch versions of the product.

Gilead already plans to license Sovaldi to as many as four Indian generic manufacturers to allow for lower-priced sales in India and 60 developing countries.